Global Toxicology Drug Screening Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Toxicology Drug Screening Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Testing Type (In Vitro, In Vivo, and In Silico), Product (Instruments, Reagenst and Consumables, Animals Models, Software, and Other Products), Application (Immunotoxicity, Systemictoxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruptions, and Other Applications), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Toxicology Drug Screening Market was valued at USD 17,210.6 million in 2023 and is expected to reach USD 35,572.0 million by 2031 while growing at a CAGR of 9.5% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global toxicology drug screening market growth. Toxicology drug screening, conducted across diverse settings like clinical labs, forensics, workplaces, and rehab centers, detects drugs or their metabolites in samples like urine, blood, saliva, or hair, aiming to pinpoint drug usage or exposure, whether from illicit substances, prescriptions, or over-the-counter medications.
Advancements in analytical technologies like mass spectrometry, chromatography, and immunoassays enhance the sensitivity, specificity, and throughput of toxicology drug screening tests, amid the increasing prevalence of substance abuse encompassing illicit drugs, prescription medications, and synthetic opioids. Nevertheless, market growth faces challenges due to cost constraints and concerns regarding privacy and legality.
Furthermore, the global toxicology drug screening industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Testing Type Analysis
The Global Toxicology Drug Screening Market is segmented among In Vitro, In Vivo, and In Silico, based on Testing Type. In 2023, In Silico accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Product Analysis
The Global Toxicology Drug Screening Market is segmented among Instruments, Reagents and Consumables, Animal Models, Software, and Other Products, based on Type. In 2023, Reagents and Consumables accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Toxicology Drug Screening Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioReliance Inc. (Merck), Charles River Laboratories International Inc., Enzo Life Sciences Inc., Eurofins Scientific, Danaher, Laboratory Corporation of America Holdings, Promega Corporation, The Jackson Laboratory, and Thermo Fisher Scientific Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Toxicology Drug Screening Market Dynamics
Drivers
Restraints
Opportunity
4. Global Toxicology Drug Screening Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Toxicology Drug Screening Market Segmentation, By Testing Type
Global Toxicology Drug Screening Market Share Analysis, By Testing Type
Global Toxicology Drug Screening Market Growth Analysis, By Testing Type
Global Toxicology Drug Screening Market Trends, By Testing Type
o In Vitro
o In Vivo
o In Silico
6. Global Toxicology Drug Screening Market Segmentation, By Product
Global Toxicology Drug Screening Market Share Analysis, By Product
Global Toxicology Drug Screening Market Growth Analysis, By Product
Global Toxicology Drug Screening Market Trends, By Product
o Instruments
o Reagents and Consumables
o Animal Models
o Software
o Other Products
7. Global Toxicology Drug Screening Market Segmentation, By Application
Global Toxicology Drug Screening Market Share Analysis, By Application
Global Toxicology Drug Screening Market Growth Analysis, By Application
Global Toxicology Drug Screening Market Trends, By Application
o Immunotoxicity
o Systemictoxicity
o Developmental and Reproductive Toxicity
o Endocrine Disruption
o Other Applications
8. Global Toxicology Drug Screening Market Segmentation, By Region
Global Toxicology Drug Screening Market Share Analysis, By Region
Global Toxicology Drug Screening Market Growth Analysis, By Region
Global Toxicology Drug Screening Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Agilent Technologies Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Bio-Rad Laboratories Inc.
BioReliance Inc. (Merck)
Charles River Laboratories International Inc.
Enzo Life Sciences Inc.
Eurofins Scientific
Danaher
Laboratory Corporation of America Holdings
Promega Corporation
The Jackson Laboratory
*Similar analysis will be provided for each company listed above.
